SGHT
Sight Sciences Inc
NASDAQ: SGHT · HEALTHCARE · MEDICAL DEVICES
$4.09
+3.02% today
Updated 2026-04-30
Market cap
$237.20M
P/E ratio
—
P/S ratio
3.07x
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$3 – $9
Volume
0.4M
Sight Sciences Inc (SGHT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.47M | $-25.00M | $-32.17M | $-52.54M | $-75.97M | $-47.18M | $-22.35M | $-29.69M |
| Capital expenditures | $570000.00 | $672000.00 | $953000.00 | $813000.00 | $970000.00 | $791000.00 | $385000.00 | $224000.00 |
| Depreciation | $63000.00 | $295000.00 | $554000.00 | $632000.00 | $710000.00 | $614000.00 | $712000.00 | — |
| Stock-based comp | $52000.00 | $118000.00 | $497000.00 | $5.08M | $12.96M | $14.58M | $17.08M | $13.05M |
| Free cash flow | $-15.04M | $-25.67M | $-33.13M | $-53.35M | $-76.94M | $-47.98M | $-22.74M | $-29.92M |
| Investing cash flow | $-570000.00 | $-672000.00 | $-953000.00 | $-813000.00 | $-970000.00 | $-791000.00 | $-385000.00 | — |
| Financing cash flow | $12.20M | $42.66M | $73.40M | $252.53M | $1.25M | $1.10M | $4.96M | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $199.18M | $-75.69M | — | — | — |